21/03/2019

VIB is very grateful to the Alzheimer Research Foundation (Stichting Alzheimer Onderzoek) for the funding the researchers received, which helps them in their quest for cures. The ​Alzheimer Research Foundation (Stichting Alzheimer Onderzoek) has been fighting Alzheimer's disease for years and is working on a future without dementia. That is why they provide financial support for scientific research into Alzheimer's disease and related brain diseases. Following researchers received a the two-year grants to help enable the research of several of the scientists of several centers. 

  • Evgenia Salta with Bart De Strooper (VIB-KU Leuven)
    Project: Systematic preclinical evaluation of microRNA-132 as a therapeutic target in Alzheimer’s disease
    Amount: 150,000 EUR
     
  • Wim Annaert (VIB-KU Leuven)
    Project: An integrated in vitro and in vivo study to unravel the function of VPS13C, the first genetic risk factor in Lewy Body disease.
    Amount: 150,000 EUR (*)
    (*) co-financing by the "Bonmariage de Bouyalski" fund managed by the King Baudouin Foundation
  • Matthew Holt (VIB-KU Leuven)
    Project: Study of the Disease Modifying Properties of an Optimized Vectored Immunoprophylaxis Approach for Alzheimer’s.
    Amount: 100,000 EUR
  • Araks Martirosyan (VIB-KU Leuven) with Matthew Holt
    Project: Astrocyte driven recovery of neuronal loss in AD brain 
    Amount: 75,000 EUR (*)
    (*) co-financing by Fund "A.B." managed by the King Baudouin Foundation.
  • Kristel Sleegers (UAntwerpen)
    Project: Predicting cognitive decline through gene expression signatures of functional connectivity
    Amount: 150,000 EUR
  • Eline Wouters (VIB-UAntwerp)
    Project: Onset age modifier of GRN-related frontotemporal lobar degeneration 
    Amount: 75,000 EUR
  • Lucia Chavez-Gutierrez (VIB-KU Leuven)​
    Project: Molecular chaperones to decipher GSEC-APP interactions and provide mechanistic underpinnings for Alzheimer’s disease therapy
    Amount: 150,000 EUR
  • Valerie Uyterhoeven (VIB-KU Leuven) with Patrik Verstreken 
    Project: Molecular mechanisms of Tau-associated presynaptic defects in Alzheimer’s
    Amount: 150,000 EUR
  • Sophie Steeland (VIB-UGent) with Roos Vandenbroucke 
    Project: Investigation of the therapeutic applicability of IL1R and TNFR1 blockage in Alzheimer’s disease
    Amount: 75,000 EUR

 

 More info about this foundation (in Dutch)

 

Research

Research